Brief: Medigene 9-month Net Loss Up 14 Pct To EUR 12.2 Million

Medigene AG

13/11/2018 06:36

Nov 13 (Reuters) - Medigene AG  MDG1k.DE :
    * 9-MONTH TOTAL REVENUE INCREASED BY 11% TO EUR 8.0 MILLION
    * 9-MONTH EBITDA LOSS INCREASED AS ANTICIPATED BY 5% TO EUR
10.7
MILLION
    * 9-MONTH NET LOSS INCREASED BY 14 % TO EUR 12.2 MILLION DUE
TO
HIGHER RESEARCH AND DEVELOPMENT EXPENSES AND CURRENCY EFFECTS
    * FURTHER IMPROVEMENT OF FINANCIAL GUIDANCE 2018
    * CONTINUES TO EXPECT TOTAL REVENUE OF EUR 9.5 - 10.5
MILLION IN
2018
    * COMPANY NOW EXPECTS TO SPEND EUR 19 - 21 MILLION FOR FULL
YEAR
2018 (PREVIOUS GUIDANCE: EUR 21 - 23 MILLION)
    * EXPECTING TO MAKE A LOSS AT EBITDA LEVEL OF EUR 16 - 18
MILLION
(PREVIOUS GUIDANCE: EUR 18 - 20 MILLION) IN 2018
    * FORECASTS A TOTAL CASH USAGE OF EUR 12 - 14 MILLION FOR
2018
(PREVIOUS GUIDANCE: EUR 15 - 17 MILLION)

Source text for Eikon:  ID:nPex4kcpta 
Further company coverage:  MDG1k.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))